Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2025-12-24 @ 11:54 PM
NCT ID:
NCT02926651
Eligibility Criteria:
Inclusion Criteria:
* older than 18 years
* scheduled for a primary cemented TKA or cementless THA
* preoperative hematocrit less than 36%
Exclusion Criteria:
* Known allergy to TXA
* acquired disturbances of color vision
* refusal of blood products
* pre-operative use of anticoagulant therapy within five days before surgery
* a history of arterial or venous thrombotic disease (including a history of Deep Vein Thrombosis, Pulmonary Embolus, Cerebrovascular accident or Transient ischemic attack)
* pregnancy, breastfeeding
* major co-morbidities (myocardial infarction or stent placement within one year, severe pulmonary disease, renal impairment, or hepatic failure)
* undergoing a revision TKA, revision THA, hip resurfacing, or Unicompartmental Knee Arthroplasty
* younger than 18 years old
* decline to participate
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02926651
Study Brief:
Protocol Section:
NCT02926651